Status:
RECRUITING
Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborating Sponsors:
University Hospital Bispebjerg and Frederiksberg
Aarhus University Hospital
Conditions:
Inflammatory Arthritis
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
Background: In patients newly diagnosed with inflammatory arthritis, a self-management intervention is anticipated to enhance self-management skills, thereby improving patient function, well-being, a...
Detailed Description
Background: Inflammatory arthritis (IA), including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), encompasses acute and chronic joint diseases characterize...
Eligibility Criteria
Inclusion
- Patients will be included if they are adults aged 18 years or older with one of the following conditions:
- Rheumatoid Arthritis (RA) with ICD-10 codes: M05.3, M05.9, M05.8, M06.9 diagnosed within the last 6 months
- Psoriatic Arthritis (PsA) with ICD-10 codes: M073.A, M073.B diagnosed within the last 6 months
- Axial Spondyloarthritis (axSpA) with ICD-10 codes: M45.9, M46.1, M46.8, M46.9, diagnosed within the last 12 months, and has initiated biological treatment
- Patients with axSpA will have unique inclusion criteria due to NSAIDs being the first-line pharmacological treatment. For those effectively treated with NSAIDs and exercise, treatment is transitioned to their general practitioner. Therefore, only those who have initiated biological treatment will be included.
Exclusion
- Patients will be excluded if they:
- have insufficient language skills to discuss the topics in the intervention in Danish
- are receiving chemo-therapy treatment for malignancies
- are pregnant
- have severe mental illness.
Key Trial Info
Start Date :
December 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06533423
Start Date
December 9 2024
End Date
December 30 2027
Last Update
December 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Center for Rheummatology and Spine Diseases
Glostrup Municipality, Denmark, 2600
2
Holbæk sygehus
Holbæk, Denmark, 4300